Alucent Biomedical Inc - Product Pipeline Analysis, 2024 Update

Alucent Biomedical Inc (Alucent Biomedical) is a biotechnology company that develops novel drug-device combination therapy for vascular diseases. The company's products include alucent natural vascular scaffolding system that consists of a balloon catheter, coated with a proprietary small-molecule, and an integrated light fiber that is designed to minimize the hemodynamic stress on the vein caused by sudden exposure to arterial pressure and flow and to promote outward remodeling of the fistula vein. Alucent Biomedical is headquartered in Salt Lake City, Utah, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Alucent Biomedical Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Alucent Biomedical Inc Company Overview
Alucent Biomedical Inc Company Snapshot
Alucent Biomedical Inc Pipeline Products and Ongoing Clinical Trials Overview
Alucent Biomedical Inc - Pipeline Analysis Overview
Alucent Biomedical Inc - Key Facts
Alucent Biomedical Inc - Major Products and Services
Alucent Biomedical Inc Pipeline Products by Development Stage
Alucent Biomedical Inc Ongoing Clinical Trials by Trial Status
Alucent Biomedical Inc Pipeline Products Overview
Natural Vascular Scaffolding Device
Natural Vascular Scaffolding Device Product Overview
Natural Vascular Scaffolding Device Clinical Trial
Natural Vascular Scaffolding Device - Arteriovenous Fistula
Natural Vascular Scaffolding Device - Arteriovenous Fistula Product Overview
Natural Vascular Scaffolding Device - Arteriovenous Fistula Clinical Trial
Natural Vascular Scaffolding Device - Below-The-Knee
Natural Vascular Scaffolding Device - Below-The-Knee Product Overview
Alucent Biomedical Inc - Key Competitors
Alucent Biomedical Inc - Key Employees
Alucent Biomedical Inc - Locations And Subsidiaries
Head Office
Recent Developments
Alucent Biomedical Inc, Recent Developments
Nov 07, 2023: Alucent Biomedical Receives Regulatory Approval for Second U.S. Clinical Study
Aug 03, 2023: FDA greenlights light-activated device for use in vascular disease trial
Jan 09, 2023: Alucent Biomedical Announces First Patient Enrolled in the First-In-Human Clinical Trial of Its Novel Alucentnvs Technology for Arteriovenous Fistula (AVF) In People With End Stage Renal Disease (ESRD)
Apr 12, 2022: Alucent Biomedical announces first patient enrolled in first in human Natural Vascular Scaffolding clinical trial
Oct 02, 2020: Alucent raises $35m for natural vascular scaffolding clinical trials
May 27, 2020: Alucent Biomedical announces first patient enrolled in phase 1 natural vascular scaffolding clinical trial
Jan 09, 2020: Alucent Biomedical announces FDA approval to proceed with Natural Vascular Scaffolding clinical trial
May 17, 2017: Alucent Medical Receives FDA Approval to Begin Clinical Trials of Novel Therapy for Vascular Disease
Appendix
Methodology
About the Analyst
Contact the Publisher
Disclaimer

List of Tables

Alucent Biomedical Inc Pipeline Products and Ongoing Clinical Trials Overview
Alucent Biomedical Inc Pipeline Products by Equipment Type
Alucent Biomedical Inc Pipeline Products by Indication
Alucent Biomedical Inc Ongoing Clinical Trials by Trial Status
Alucent Biomedical Inc, Key Facts
Alucent Biomedical Inc, Major Products and Services
Alucent Biomedical Inc Number of Pipeline Products by Development Stage
Alucent Biomedical Inc Pipeline Products Summary by Development Stage
Alucent Biomedical Inc Ongoing Clinical Trials by Trial Status
Alucent Biomedical Inc Ongoing Clinical Trials Summary
Natural Vascular Scaffolding Device - Product Status
Natural Vascular Scaffolding Device - Product Description
Natural Vascular Scaffolding Device - A Study of the Safety and Feasibility of the Vessel Restoration System for AVF to Promote the Physiologic and Functional Maturation of Upper-extremity Autologous End-to-Side Arteriovenous Fistulas (AVF) in Patients With Chronic Kidney Disease: ACTIVATE AVF
Natural Vascular Scaffolding Device - Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) After Sub-optimal Percutaneous Transluminal Angioplasty (PTA) or Atherectomy: REACTIVATE I
Natural Vascular Scaffolding Device - Study to Evaluate the Safety and Efficacy of the Alucent Natural Vascular Scaffolding (Alucentnvs) Vessel Restoration System with Photoactivated Linking in the Treatment of Peripheral Artery Disease (PAD) of the Lower Extremities
Natural Vascular Scaffolding Device - Arteriovenous Fistula - Product Status
Natural Vascular Scaffolding Device - Arteriovenous Fistula - Product Description
Natural Vascular Scaffolding Device - Arteriovenous Fistula - The Clinical Study To Evaluate the Success Rate of AV fistula Maturation by Using the AlucentNVS Technology
Natural Vascular Scaffolding Device - Below-The-Knee - Product Status
Natural Vascular Scaffolding Device - Below-The-Knee - Product Description
Alucent Biomedical Inc, Key Employees
Glossary

List of Figures

Alucent Biomedical Inc Pipeline Products by Equipment Type
Alucent Biomedical Inc Pipeline Products by Development Stage
Alucent Biomedical Inc Ongoing Clinical Trials by Trial Status

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

ExThera Medical Corp
Orchestra BioMed Inc
MedWaves Inc
B. Braun Medical Inc
Waters Medical Systems LLC